History for GSK

Year Qtr # Shares Change
2022 Q1 391,090 +17,666
2021 Q4 373,424
2021 Q1 0 Liquidated
2020 Q4 299,541 +32,072
2020 Q3 267,469 -10,690
2020 Q2 278,159 +44,871
2020 Q1 233,288 +19,821
2019 Q4 213,467 +36,818
2019 Q3 176,649 -36,540
2019 Q2 213,189 -18,493
2019 Q1 231,682 -99,126
2018 Q4 330,808 -11,740
2018 Q3 342,548 -881
2018 Q2 343,429 +7,422
2018 Q1 336,007 -52,874
2017 Q4 388,881 +45,420
2017 Q3 343,461 +31,611
2017 Q2 311,850 -92,681
2017 Q1 404,531 +60,711
2016 Q4 343,820 +70,787
2016 Q3 273,033 -37,621
2016 Q2 310,654 -13,443
2016 Q1 324,097 -133,828
2015 Q4 457,925 +39,946
2015 Q3 417,979 -33,043
2015 Q2 451,022 +93,170
2015 Q1 357,852 -18,408
2014 Q4 376,260 -48,151
2014 Q3 424,411 +114,294
2014 Q2 310,117 +23,196
2014 Q1 286,921 +40,790
2013 Q4 246,131 +12,356
2013 Q3 233,775 -19,855
2013 Q2 253,630 +241,451
2013 Q1 12,179 +3,195
2012 Q4 8,984 -1,226
2012 Q3 10,210 +270
2012 Q2 9,940